Management of ovarian cysts

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 11, 2004, Pages 1012-1021

  Knudsen, Ulla Breth ^a   Tabor, Ann ^b   Mosgaard, Berit ^c   Andersen, Erik Soegaard ^d   Kjer, Jens Joergen ^e   Hahn Pedersen, Suzanne ^f   Toftager Larsen, Kim ^g   Mogensen, Ole ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f Hilleroed Hospital ^*

^g HILLERØD HOSPITAL   (Denmark)

Author keywords

CA 125; Ovarian cysts; Ovarian cysts and pregnancy; Ovarian masses; Risk of malignancy index

Indexed keywords

CA 125 ANTIGEN; ESTROGEN; ORAL CONTRACEPTIVE AGENT;

AGE DISTRIBUTION; ANTIGEN DETECTION; BENIGN TUMOR; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; ECHOGRAPHY; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; LAPAROSCOPIC SURGERY; MALIGNANT NEOPLASTIC DISEASE; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; OVARY CYST; OVARY TUMOR; POSTMENOPAUSE; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PUNCTURE; REVIEW; TREATMENT INDICATION; TUMOR VOLUME;

CA-125 ANTIGEN; FEMALE; HUMANS; OVARIAN CYSTS; OVARIAN NEOPLASMS; PRACTICE GUIDELINES;

EID: 7644220181     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.00607.x     Document Type: Review

References (86)

1. Borgfeldt C, Andolf E. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultrasound Obstet Gynecol 1999; 13: 345-50.
2. Bailey CL, Ueland FR, Land GL, DePriest PD, Gallion HH, Kryscio RJ et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 1998; 69: 3-7.
3. American Cancer Society: Cancer Facts and Figures - 1998. Atlanta, GA: American Cancer Society, 1998.
4. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BAJ. A systematic review and meta-analysis of family history and risk of ovarian cancer. BJOG 1998; 105: 493-9.
5. Sutcliffe S, Pharoah PDP, Easton DF, Ponder BAJ. Ovarian and Breast cancer risks to women in families with two or more cases of ovarian cancer. Int J Cancer 2000; 87: 110-7.
6. Okugawa K, Hirakawa T, Fukushima K, Kamura T, Amada S, Nakano H. Relationship between age, histological type, and size of ovarian tumors. Int J Gynecol Obstet 2001; 74: 45-50.
7. Yancik R. Ovarian cancer. Age contrasts in incidence, histology, disease stage, diagnosis, and mortality. Cancer 1993; 71 (Suppl. 2): 517-23.
8. Danish National Board of Health. Cancer Incidence in Denmark. Copenhagen: The Danish National Board of Health, Statistical Office, 1997.
9. Benedet JL, Bender H, Jones H III, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guideline in the management of gynaecologic cancers. FIGO Committee on Gynaecologic Oncology. Int J Gynaecol Obstet 2000; 70: 209-62.
10. Maggino T, Gadducci A, D'Addario V, Pecorelli S, Lissoni A, Stella M et al. Prospective multicenter study on CA-125 in postmenopausal pelvic masses. Gynecol Oncol 1994; 54: 117-23.
11. Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer. Obstet Gynecol 2001; 98: 212-7.
12. Amer SA, Li TC, Bygrave C, Sprigg A, Saravelos H, Cooke ID. An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries. Hum Reprod 2002; 17: 1616-22.
13. Christensen JT, Boldsen JL, Westergaard JG. Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 2002; 66: 153-7.
14. Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol 2000; 16: 500-5.
15. Osmers ROW, Osmers M, von Maydell B, Wagner B, Kuhn W. Preoperative evaluation of ovarian tumors in the premenopause by transvaginosonography. Am J Obstet Gynecol 1996; 175: 428-34.
16. Osmers ROW, Osmers M, von Maydell B, Kuhn W. Evaluation of ovarian tumors in the postmenopause by transvaginosonography. Eur J Obstet Gynecol Reprod 1998; 77: 81-8.
17. Ekerhovd E, Wienerroith H, Staudach A, Granberg S. Preoperative assessment of unilocular adnexal cysts by transvaginal ultrasonography: a comparison between ultrasonographic morphologic imaging and histopathologic diagnosis. Am J Obstet Gynecol 2001; 184: 48-54.
18. Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ, vanNagell JR. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol 2003; 102: 594-9.
19. Roman LD. Small cystic pelvic masses in older women: is surgical removal necessary? Gynecol Oncol 1998; 69: 1-2.
20. Levine D, Gosink BB, Wolf SI, Feldesman MR, Pretorius DH. Simple adnexal cysts: the natural history in postmenopausal women. Radiology 1992; 184: 653-9.
21. Granberg S, Wikland M, Jansson I. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol 1989; 35: 139-44.
22. Minaretzis D, Tsionou C, Tziotziotis D, Michalas S, Aravantinos D. Ovarian tumors: prediction of the probability of malignancy by using patient's age and tumor morphologic features with a logistic model. Gynecol Obstet Invest 1994; 38: 140-4.
23. Valentin L, Sladekevicius P, Marsal K. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol 1994; 83: 425-33.
24. DePriest PD, Varner E, Powell J, Puls L, Higgins R, Shenson D et al. The efficacy of a sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation. Gynecol Oncol 1994; 55: 174-8.
25. Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991; 78: 70-6.
26. Guerriero S, Alcazar JL, Coccia ME, Ajossa S, Scarselli G, Boi M et al.Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler sonography for the diagnosis of adnexal malignancies: results of a multicenter European study. J Ultrasound Med 2002; 21: 1105-11.
27. Kinkel K, Hricak H, Lu Y, Tsuda K, Filly RA. US characterization of ovarian masses: a meta-analysis. Radiology 2000; 217: 803-11.
28. Guerriero S, Mallarini G, Ajossa S, Risalvato A, Satta R, Mais V et al. Transvaginal ultrasound and computed tomography combined with clinical parameters and CA-125 determinations in the differential diagnosis of persistent ovarian cysts in premenopausal women. Ultrasound Obstet Gynecol 1997; 9: 339-43.
29. Acar B, Posaci C, Dicle O, Topuz A, Erten O. Diagnostic value of magnetic resonance imaging in gynaecology. Aust N Z J Obstet Gynaecol 1992; 32: 252-5.
30. Kinoshita T, Ishii K, Naganuma H, Higashiiwai H. MR findings of ovarian tumors with cystic components. Br J Radiol 2000; 73: 333-9.
31. Pretorius ES, Outwater EK, Hunt JL, Siegelman ES. Magnetic resonance imaging of the ovary. Top Magn Reson Imaging 2001; 12: 131-46.
32. Kurtz AB, Tsimikas JV, Tempany CMC, Hamper UM, Arger PH, Bree RL et al. Diagnosis and staging of ovarian cancer: comparative values of doppler and conventional US, CT, and MR Imagining correlated with surgery and histopathologic analysis - report of the radiology diagnostic oncology group. Radiology 1999; 212: 19-27.
33. De Crespigny LC, Robinson H, Davoren RAM, Fortune D. The simple ovarian cyst: aspirate or operate ? BJOG 1989; 96: 1035-9.
34. Moran O, Menczer J, Ben-Baruch G, Lipitz S, Goor E. Cytologic examination of ovarian cyst fluid for the distinction between benign and malignant tumors. Obstet Gynecol 1993; 82: 444-6.
35. Zanetta G, Lissoni A, Torri V, Valle CV, Trio D, Rangoni G et al. Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study. Br Med J 1996; 313: 1110-3.
36. Martínez-Onsurbe P, Villaespesa AR, Anquela JMS, Ruiz PLV. Aspiration cytology of 147 adnexal cysts with histologic correlation. Acta Cytol 2001; 45: 941-7.
37. Vergote I, De Brabanter J, Fyles A, Berteisen K, Einhorn N, Sevelda P et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001; 357: 176-82.
38. Finkler NJ, Benacerraf B, Lavin PT, Wojciechowski C, Knapp RC. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses. Obstet Gynecol 1988; 72: 659-64.
39. Franchi M, Beretta P, Ghezzi F, Zanaboni F, Goddi A, Salvatore S. Diagnosis of pelvic masses with transabdominal color doppler, CA 125 and ultrasonography. Acta Obstet Gynecol Scand 1995; 74: 734-9.
40. Malkasian GD, Knapp RC, Lavin PT, Zurawski VR, Podratz KC, Stanhope CR et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol 1988; 159: 341-6.
41. Mogensen O, Mogensen B, Jakobsen A. Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic masses. Gynecol Oncol 1990; 38: 17-4.
42. Patsner B, Mann WJ. The value of preoperative serum CA 125 levels in patients with a pelvic mass. Am J Obstet Gynecol 1988; 159: 873-6.
43. Vasilev SA, Schlaerth JB, Campeau J, Morrow CP. Serum CA 125 levels in preoperative evaluation of pelvic masses. Obstet Gynecol 1988; 71: 751-6.
44. Davies AP, Jacobs I, Woolas R, Fish A, Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. BJOG 1993; 100: 927-31.
45. Zurawski VR, Sjovall K, Schoenfeld DA, Broderick SF, Hall P, Bast RC Jr et al. Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer. Gynecol Oncol 1990; 36: 299-305.
46. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. BJOG 1990; 97: 922-9.
47. Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T et al. Evaluation of a risk of malignancy index based on serum CA 125, ultrasound findings and the menopausal status in the pre-operative diagnosis of pelvic masses. BJOG 1996; 103: 826-31.
48. Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol 1999; 93: 448-52.
49. Soegaard Andersen E, Knudsen A, Rix P, Johansen B. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol 2003; 90: 109-12.
50. Sasaki H, Oda M, Ohmura M, Akiyama M, Liu C, Tsugane S et al. Follow up of women with simple ovarian cysts detected by transvaginal sonography in Tokyo metropolitan area. Br J Obstet Gynecol 1999; 106: 415-20.
51. Lanes SF, Birmann B, Walker AM, Singer S. Oral contraceptive type and functional ovarian cysts. Am J Obstet Gynecol 1992; 166: 956-61.
52. Holt VL, Daling JR, McKnight B, Moore D, Stergachis A, Weiss NS. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstet Gynecol 1992; 79: 529-33.
53. Holt VL, Cushing-Haugen KL, Darling JR. Oral contraceptives, tubal sterilization, and functional ovarian cyst risk. Obstet Gynecol 2003; 102: 252-8.
54. Chiaffarino F, Parazzini F, Vecchia CL, Ricci E, Crosignani PG. Oral contraceptive use and benign gynecologic conditions. Contraception 1998; 57: 11-8.
55. MacKenna A, Fabres C, Alam V, Morales V. Clinical management of functional ovarian cysts: a prospective and randomized study. Hum Reprod 2000; 15: 2567-9.
56. Bar-Hava I, Orvieto R, Vardimon D, Manor Y, Weissman A, Nelinger R et al. Ovarian cysts and cyclic hormone replacement therapy: is there an association? Acta Obstet Gynecol Scand 1997; 76: 563-6.
57. Yuen PM, Yu KM, Yip SK, Lau WC, Rogers MS, Chang A. A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol 1997; 177: 109-14.
58. Muzii L, Bianchi A, Crocé C, Manci N, Panici PB. Laparoscopic excision of ovarian cysts: is the stripping technique a tissue-sparing procedure? Fertil Steril 2002; 77: 609-14.
59. Hill LM, Connors-Beatty DJ, Nowak A, Tush B. The role of ultrasonography in the detection and management of adnexal masses during the second and third trimesters of pregnancy. Am J Obstet Gynecol 1998; 179: 703-7.
60. Hess LW, Peaceman A, O'Brien WF, Winkel CA, Cruikshank DP, Morrison JC. Adnexal mass occurring with intrauterine pregnancy: report of fifty-four patients requiring laparotomy for definitive management. Am J Obstet Gynecol 1988; 158: 1029-34.
61. Whitecar MP, Turner S, Higby MK. Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol 1999; 181: 19-24.
62. Bromley B, Benacerraf B. Adnexal masses during pregnancy: accuracy of sonographic diagnosis and outcome. J Ultrasound Med 1997; 16: 447-52.
63. Usui R, Minakami H, Kosuge S, Iwasaki R, Ohwada M, Sato I. A retrospective survey of clinical, pathologic, and prognostic features of adnexal masses operated on during pregnancy. J Obstet Gynaecol Res 2000; 26: 89-93.
64. Wang PH, Yuan CC, Chao HT, Yu KJ, Tseng JY, Hung JH et al. Ovarian surgery during pregnancy and puerperium: twelve-year experience at the Veterans General Hospital-Taipei. Zhonghua Yi Xue Za Zhi (Taipei) 1998; 61: 324-31.
65. Zanetta G, Mariani E, Lissoni A, Ceruti P, Trio D, Strobelt N et al. A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy. BJOG 2003; 110: 578-83.
66. Kobayashi H, Yoshida A, Kobayashi M, Yamada T. Changes in size of the functional cyst on ultrasonography during early pregnancy. Am J Perinatol 1997; 14: 1-4.
67. Bernhard LM, Klebba PK, Gray DL, Mutch DG. Predictors of persistence of adnexal masses in pregnancy. Obstet Gynecol 1999; 93: 585-9.
68. Thornton JG, Wells M. Ovarian cysts in pregnancy: does ultrasound make traditional management inappropriate? Obstet Gynecol 1987; 69: 717-21.
69. Caspi B, Levi R, Appelman Z, Rabinerson D, Goldman G, Hagay Z. Conservative management of ovarian cystic teratoma during pregnancy and labor. Am J Obstet Gynecol 2000; 182: 503-5.
70. Aslam N, Ong C, Woelfer B, Nicolaides K, Jurkovic D. Serum CA125 at 11-14 weeks of gestation in women with morphologically normal ovaries. BJOG 2000; 107: 689-90.
71. Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, van Kamp GJ et al. Maternal serum CA 125 and CA 15-3 antigen levels in normal and pathological pregnancy. Fetal Diagn Ther 2001; 16: 166-72.
72. Kobayashi F, Takashima E, Sagawa N, Mori T, Fujii S. Maternal serum CA 125 levels in early intrauterine and tubal pregnancies. Arch Gynecol Obstet 1993; 252: 185-9.
73. Soriano D, Yefet Y, Seidman DS, Goldenberg M, Mashiach S, Oelsner G. Laparoscopy versus laparotomy in the management of adnexal masses during pregnancy. Fertil Steril 1999; 71: 955-60.
74. Wang PH, Chao HT, Yuan CC, Lee WL, Chao KC, Ng HT. Ovarian tumors complicating pregnancy. Emergency and elective surgery. J Reprod Med 1999; 44: 279-87.
75. Moore RD, Smith WG. Laparoscopic management of adnexal masses in pregnant women. J Reprod Med 1999; 44: 97-100.
76. Parker WH, Childers JM, Canis M, Phillips DR, Topel H. Laparoscopic management of benign cystic teratomas during pregnancy. Am J Obstet Gynecol 1996; 174: 1499-501.
77. Yuen PM, Chang AM. Laparoscopic management of adnexal mass during pregnancy. Acta Obstet Gynecol Scand 1997; 76: 173-6.
78. Caspi B, Ben-Arie A, Appelman Z, Or Y, Hagay Z. Aspiration of simple pelvic cysts during pregnancy. Gynecol Obstet Invest 2000; 49: 102-5.
79. Guariglia L, Conte M, Are P, Rosati P. Ultrasound-guided fine needle aspiration of ovarian cysts during pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 82: 5-9.
80. Platek DN, Henderson CE, Goldberg GL. The management of a persistent adnexal mass in pregnancy. Am J Obstet Gynecol 1995; 173: 1236-40.
81. Lachman E, Schienfeld A, Voss E, Gino G, Soldes R, Levine S et al. Pregnancy and laparoscopic surgery. J Am Assoc Gynecol Laparosc 1999; 6: 347-51.
82. Akira S, Yamanaka A, Ishihara T, Takeshita T, Araki T. Gasless laparoscopic ovarian cystectomy during pregnancy: comparison with laparotomy. Am J Obstet Gynecol 1999; 180: 554-7.
83. Aslam N, Banerjee S, Carr JV, Savvas M, Hooper R, Jurkovic D. Prospective evaluation of logistic regression models for the diagnosis of ovarian cancer. Obstet Gynecol 2000; 96: 75-80.
84. Timmerman D, Verrelst H, Bourne TH, De Moor B, Collins WP, Vergote I et al. Artificial neural network models for the pre-operative discrimination between malignant and benign adnexal masses. Ultrasound Obstet Gynecol 1999; 13: 17-25.
85. Boll D, Geomini PMAJ, Brölmann HAM, Sijmons EA, Heintz PM, Mol BWJ. The pre-operative assesment of the adnexal mass: the accuracy of clinical estimates versus clinical prediction rules. BJOG 2003; 110: 519-23.
86. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572-7.